We now asked whether this model could also help to improve our understanding of CIDP treatments and we therefore tested whether IVIg are effective in ICAM-1-/-NOD mice. The gene discussed is ICAM1; the disease is chronic inflammatory demyelinating polyradiculoneuropathy.